Cherbut C, Ferrier L, Rozé C, Anini Y, Blottière H, Lecannu G, Galmiche J P
Human Nutrition Research Center, Institut National de la Recherche Agronomique, Centre Hospitalier de Nantes, Hôtel Dieu, 44035 Nantes Cedex 1, France.
Am J Physiol. 1998 Dec;275(6):G1415-22. doi: 10.1152/ajpgi.1998.275.6.G1415.
Short-chain fatty acids (SCFAs) are recognized as the major anions of the large intestinal content in humans, but their effect on colonic motility is controversial. This study explores the colonic motor effect of SCFAs and their mechanisms in the rat. Colonic motility (electromyography) and transit time (plastic markers) were measured in conscious rats while SCFAs were infused into the colon, either alone or after administration of neural antagonists or immunoneutralization of circulating polypeptide YY (PYY). SCFA-induced PYY release was measured by RIA and then simulated by infusing exogenous PYY. Intracolonic infusion of 0.4 mmol/h SCFAs had no effect, whereas 2 mmol/h SCFAs reduced colonic motility (36 +/- 3 vs. 57 +/- 4 spike bursts/h with saline, P < 0.05) by decreasing the ratio of nonpropulsive to propulsive activity. This resulted in an increased transit rate (P < 0.01). Neither alpha-adrenoceptor blockade nor nitric oxide synthase inhibition prevented SCFA-induced motility reduction. Intraluminal procaine infusion suppressed the SCFA effect, indicating that a local neural mechanism was involved. SCFA colonic infusion stimulated PYY release in blood. Immunoneutralization of circulating PYY abolished the effect of SCFAs on colonic motility, whereas exogenous PYY infusion partly reproduced this effect. SCFAs modify colonic motor patterns in the rat and increase transit rate; local nerve fibers and PYY are involved in this effect.
短链脂肪酸(SCFAs)被认为是人类大肠内容物中的主要阴离子,但其对结肠运动的影响存在争议。本研究探讨了SCFAs对大鼠结肠运动的影响及其机制。在清醒大鼠中,将SCFAs单独或在给予神经拮抗剂或对循环中的多肽YY(PYY)进行免疫中和后注入结肠,同时测量结肠运动(肌电图)和转运时间(塑料标记物)。通过放射免疫分析法(RIA)测量SCFA诱导的PYY释放,然后通过注入外源性PYY进行模拟。结肠内以0.4 mmol/h的速度注入SCFAs没有效果,而以2 mmol/h的速度注入SCFAs会降低结肠运动(生理盐水组为57±4次棘波爆发/小时,SCFAs组为36±3次棘波爆发/小时,P<0.05),这是通过降低非推进性活动与推进性活动的比例实现的。这导致转运速率增加(P<0.01)。α-肾上腺素能受体阻断和一氧化氮合酶抑制均不能阻止SCFA诱导的运动性降低。腔内注入普鲁卡因可抑制SCFA的作用,表明涉及局部神经机制。结肠内注入SCFAs可刺激血液中PYY的释放。对循环中的PYY进行免疫中和可消除SCFAs对结肠运动的影响,而注入外源性PYY可部分重现这种影响。SCFAs可改变大鼠的结肠运动模式并增加转运速率;局部神经纤维和PYY参与了这一作用。